US4057059A
(en)
*
|
1975-07-29 |
1977-11-08 |
Oklahoma State University |
Intermittent positive pressure breathing device
|
US4060078A
(en)
*
|
1975-08-18 |
1977-11-29 |
Bird F M |
Ventilator and method
|
US4003377A
(en)
*
|
1975-08-21 |
1977-01-18 |
Sandoz, Inc. |
Patient ventilator
|
US4098272A
(en)
*
|
1975-09-25 |
1978-07-04 |
Bio-Med Devices Inc. |
Respirator
|
US4141356A
(en)
*
|
1976-06-16 |
1979-02-27 |
Bourns, Inc. |
Respirator system and method
|
US4148312A
(en)
*
|
1976-10-08 |
1979-04-10 |
Minnesota Mining And Manufacturing Company |
Combination anesthesia and intensive care apparatus
|
US4155357A
(en)
*
|
1976-12-10 |
1979-05-22 |
Sandoz, Inc. |
Patient ventilator disconnect alarm
|
JPS5447900U
(xx)
*
|
1977-09-09 |
1979-04-03 |
|
|
US4197843A
(en)
*
|
1978-04-03 |
1980-04-15 |
Minnesota Mining And Manufacturing Company |
Volume limiting ventilator
|
EP0074943B1
(en)
*
|
1981-03-26 |
1986-06-18 |
Vas-Es Müszeripari Szövetkezet |
Respirator device, particularly for use in perinatal medicine
|
DE3126207C2
(de)
*
|
1981-07-03 |
1983-11-17 |
Drägerwerk AG, 2400 Lübeck |
Zeitgesteuertes Beatmungsgerät
|
US4448192A
(en)
*
|
1982-03-05 |
1984-05-15 |
Hewlett Packard Company |
Medical ventilator device parametrically controlled for patient ventilation
|
US4459982A
(en)
*
|
1982-09-13 |
1984-07-17 |
Bear Medical Systems, Inc. |
Servo-controlled demand regulator for respiratory ventilator
|
US4702240A
(en)
*
|
1986-07-22 |
1987-10-27 |
Bear Medical Systems, Inc. |
Demand-responsive gas blending system for medical ventilator
|
US4931285A
(en)
*
|
1988-04-28 |
1990-06-05 |
Alza Corporation |
Aqueous based pharmaceutical coating composition for dosage forms
|
US5111809A
(en)
*
|
1988-12-01 |
1992-05-12 |
Avstar Aerospace Corporation |
Breathing system
|
DE3900276A1
(de)
*
|
1989-01-07 |
1990-07-12 |
Draegerwerk Ag |
Beatmungsgeraet mit atemkreislauf und gesteuerter frischgaszufuhr
|
US5086767A
(en)
*
|
1990-09-26 |
1992-02-11 |
Canadian Aging & Rehabilitation Product Development Corporation |
Ventilator for assisting the breathing of a patient
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
GB2282542B
(en)
*
|
1993-10-06 |
1997-06-25 |
Instruments & Movements Ltd |
Ventilators for promoting lung function
|
US5411745A
(en)
*
|
1994-05-25 |
1995-05-02 |
Euro-Celtique, S.A. |
Powder-layered morphine sulfate formulations
|
US6077533A
(en)
*
|
1994-05-25 |
2000-06-20 |
Purdue Pharma L.P. |
Powder-layered oral dosage forms
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
FI974148A
(fi)
|
1997-11-05 |
1999-05-06 |
Instrumentarium Oy |
Menetelmä ja sovitelma hengityslaitteen yhteydessä
|
US6375957B1
(en)
|
1997-12-22 |
2002-04-23 |
Euro-Celtique, S.A. |
Opioid agonist/opioid antagonist/acetaminophen combinations
|
PT1685839E
(pt)
|
1997-12-22 |
2013-07-08 |
Euro Celtique Sa |
Forma de dosagem farmacêutica por via oral compreendendo uma combinação de um agonista opióide e de um antagonista opióide
|
AU1828599A
(en)
*
|
1997-12-29 |
1999-07-19 |
Alza Corporation |
Osmotic delivery system with membrane plug retention mechanism
|
ATE248002T1
(de)
|
1997-12-31 |
2003-09-15 |
Alza Corp |
System zur überwachung einer osmotischen wirkstoffabgabevorrichtung
|
TW407058B
(en)
|
1998-07-17 |
2000-10-01 |
Dev Center Biotechnology |
Oral cisapride dosage forms with an extended duration
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
KR20130010512A
(ko)
|
1999-10-29 |
2013-01-28 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
ATE405264T1
(de)
|
2000-02-08 |
2008-09-15 |
Euro Celtique Sa |
Zusammensetzungen mit kontrollierter freisetzung, die einen opioid agonist und antagonist enthalten
|
AU776904B2
(en)
|
2000-02-08 |
2004-09-23 |
Euro-Celtique S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
KR100960200B1
(ko)
|
2000-10-30 |
2010-05-27 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
DE60238756D1
(de)
|
2001-05-11 |
2011-02-10 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
AU2002324624A1
(en)
|
2001-08-06 |
2003-02-24 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
JP4504013B2
(ja)
|
2001-08-06 |
2010-07-14 |
ユーロ−セルティーク エス.エイ. |
放出可能な及び封鎖されたアンタゴニストを有するオピオイドアゴニスト製剤
|
US7387123B2
(en)
*
|
2001-11-30 |
2008-06-17 |
Viasys Manufacturing, Inc. |
Gas identification system and volumetrically correct gas delivery system
|
DE20308437U1
(de)
*
|
2002-04-05 |
2003-11-13 |
Euroceltique S.A., Luxemburg/Luxembourg |
Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
|
DE60335426D1
(de)
|
2002-08-15 |
2011-01-27 |
Euro Celtique Sa |
Pharmazeutische Zusammensetzungen enthaltend einen Opioidantagonisten
|
US7267120B2
(en)
|
2002-08-19 |
2007-09-11 |
Allegiance Corporation |
Small volume nebulizer
|
EP2422775A3
(en)
|
2002-09-20 |
2012-04-18 |
Alpharma, Inc. |
Sequestering subunit and related compositions and methods
|
ATE482695T1
(de)
|
2002-12-13 |
2010-10-15 |
Durect Corp |
Orale darreichungsform mit flüssigen hochviskosen trägersystemen
|
EP2339328A3
(en)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical co-crystal compositions of celecoxib
|
MY135852A
(en)
|
2003-04-21 |
2008-07-31 |
Euro Celtique Sa |
Pharmaceutical products
|
PL1663229T3
(pl)
|
2003-09-25 |
2010-09-30 |
Euro Celtique Sa |
Farmaceutyczne kombinacje hydrokodonu i naltreksonu
|
CA2548917C
(en)
|
2003-12-11 |
2014-09-23 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
EP1604667A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the restless leg syndrome
|
EP1604666A1
(en)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
|
CA2569958C
(en)
|
2004-06-12 |
2016-03-22 |
Jane C. Hirsh |
Abuse-deterrent drug formulations
|
WO2006007351A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Squeeze controlled oral dosage form
|
EP1771160A2
(en)
*
|
2005-01-28 |
2007-04-11 |
Euroceltique S.A. |
Alcohol resistant dosage forms
|
EP1702558A1
(en)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Method and device for the assessment of bowel function
|
EP1695700A1
(en)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Dosage form containing oxycodone and naloxone
|
EP1813276A1
(en)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Tamper resistant dosage forms
|
SI2484346T1
(sl)
|
2006-06-19 |
2017-05-31 |
Alpharma Pharmaceuticals Llc |
Farmacevtski sestavki
|
EP2019101A1
(en)
*
|
2007-07-26 |
2009-01-28 |
GPC Biotech AG |
Pyrazol[3,4-d]pyrimidin-4-one useful as Kinase Inhibitor
|
AU2008335809A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
AR074760A1
(es)
*
|
2008-12-18 |
2011-02-09 |
Metabolex Inc |
Agonistas del receptor gpr120 y usos de los mismos en medicamentos para el tratamiento de diabetes y el sindrome metabolico.
|
PT2405915T
(pt)
|
2009-03-10 |
2019-01-29 |
Euro Celtique Sa |
Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
PE20181177A1
(es)
|
2010-12-22 |
2018-07-20 |
Purdue Pharma Lp |
Formas de dosis de liberacion controlada encerradas resistentes a manipulaciones indebidas
|
CN103327969A
(zh)
|
2010-12-23 |
2013-09-25 |
普渡制药公司 |
抗篡改固体口服剂型
|
US9630979B2
(en)
|
2011-09-29 |
2017-04-25 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
EA201500742A1
(ru)
|
2013-02-05 |
2015-12-30 |
Пердью Фарма Л.П. |
Защищенные от нецелевого использования фармацевтические композиции
|
TW201521769A
(zh)
|
2013-03-15 |
2015-06-16 |
Durect Corp |
具有流變改質劑以減少溶解變異性之組成物
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
NZ716267A
(en)
|
2013-07-23 |
2017-05-26 |
Euro Celtique Sa |
A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
|
WO2015107471A1
(en)
|
2014-01-15 |
2015-07-23 |
Rhodes Technologies |
Process for improved oxycodone synthesis
|
US10201667B2
(en)
|
2015-03-26 |
2019-02-12 |
Becton, Dickinson And Company |
IV membrane attachment systems and methods
|
US10232130B2
(en)
|
2015-03-26 |
2019-03-19 |
Becton, Dickinson And Company |
Anti-run dry membrane
|
US10702689B2
(en)
|
2015-03-26 |
2020-07-07 |
Becton, Dickinson And Company |
Auto-stop vent plug
|
US10646648B2
(en)
|
2015-04-01 |
2020-05-12 |
Becton, Dickinson And Company |
IV flow management systems and methods
|
WO2017222575A1
(en)
|
2016-06-23 |
2017-12-28 |
Collegium Pharmaceutical, Inc. |
Process of making more stable abuse-deterrent oral formulations
|
US10820833B2
(en)
|
2016-12-09 |
2020-11-03 |
Physio-Control, Inc. |
Capnograph system further detecting spontaneous patient breaths
|
WO2021188909A1
(en)
*
|
2020-03-19 |
2021-09-23 |
The Regents Of The University Of California |
Mechanical ventilator with a fixed number of orifice plates to generate constant flow paths
|